Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
Status: Open
- Who can apply
- Nonprofits, small businesses, state, local and tribal governments, tribes, schools and universities, for-profit companies, others.
- Deadline
- Friday, January 7, 2028 - check the notice for the exact time
- Opened Nov 6, 2024
- Amount
- Not stated by the source
- Official source
- Read and apply at the official source Found on grants.gov
- Requirements
- Documents with the official notice: PAR-25-145-Full-Announcement.html
- Organizations need a SAM.gov ID number (UEI) to apply. Individuals do not.
- Application fee
- We do not read fees from notices; check the official notice. GrantsWindow never charges you.
- Funder
- National Institutes of Health (federal)
- Assistance Listing 93.393
- Last checked
- Checked Nov 15, 2026 at the official source
From the official notice
The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic comorbidities or develop as delayed posttreatment effects. This FOA supports basic, translational, and ...
Topics this may fit (our guess)
minority-serving